MedPath

EFFECT OF PAROXETINE AND FLUOXETINE ON GUM HEALTH IN PATIENTS OF DEPRESSION AND PYORRHEA.

Not Applicable
Conditions
Health Condition 1: F320- Major depressive disorder, singleepisode, mild
Registration Number
CTRI/2021/11/037995
Lead Sponsor
DR SINAM SUBHASCHANDRA SINGH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with depression and periodontitis.

2.Patient should have minimum 20 teeth other than third molars.

Periodontitis criteria

Stage 1 and 2 generalized Periodontitis patients as per the 2017 periodontitis classification

Depression criteria

Diagnosis of depression will be made using ICD-10 criteria,

In typical depressive episodes of all three varieties

a.(mild (F32.0),

b.moderate (F32.1), and

c.severe (F32.2 and F32.3)

Exclusion Criteria

1.History of systemic disease or condition that is reported to be associated with periodontal disease, including diabetes mellitus, osteoporosis, rheumatoid arthritis, chronic renal failure, cardiovascular disease, and pregnancy.

2.Treatment with the following drugs in the previous 3 months: antibiotics, anti-inflammatories, steroids, immunosuppressants, lipid-lowering drugs, anticoagulants, bisphosphonates, and host modulatory drugs.

3.Patients on anyantidepressant medication besides Paroxetine andFluoxetine.

4.Patients who have undergone periodontal treatment (non-surgical or surgical) 6 months prior to the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath